A detailed history of Alyeska Investment Group, L.P. transactions in Danaher Corp stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 284,292 shares of DHR stock, worth $65 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
284,292
Previous 245,932 15.6%
Holding current value
$65 Million
Previous $61.4 Million 28.62%
% of portfolio
0.44%
Previous 0.37%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $9.18 Million - $10.8 Million
38,360 Added 15.6%
284,292 $79 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $1.29 Million - $1.47 Million
-5,488 Reduced 2.18%
245,932 $61.4 Million
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $2.96 Million - $3.38 Million
13,180 Added 5.53%
251,420 $62.8 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $839,428 - $1.06 Million
-4,535 Reduced 1.87%
238,240 $55.1 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $53.4 Million - $60.8 Million
-237,225 Reduced 49.42%
242,775 $58.3 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $41.7 Million - $48.2 Million
173,961 Added 56.84%
480,000 $121 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $73.9 Million - $86.4 Million
306,039 New
306,039 $81.2 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $6.64 Million - $8.4 Million
28,019 Added 347.03%
36,093 $9.15 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $54.1 Million - $75.4 Million
-445,910 Reduced 98.22%
8,074 $1.12 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $13 Million - $14.9 Million
-103,776 Reduced 18.61%
453,984 $0
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $12.9 Million - $17.4 Million
131,652 Added 30.9%
557,760 $0
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $40.4 Million - $46.7 Million
426,108 New
426,108 $43.9 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.